person · Reporting owner

BEGEMANN BRETT D

Disclosed activity across 2 companies

Tapewire entity: 48472
SEC CIK: 0001243982

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
EASTMAN CHEMICAL COEMN · Entity 1780	Director	October 07, 2026	October 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

EASTMAN CHEMICAL CO

Report date October 07, 2026 · Filed October 09, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	61,396	Reported balance After 2026-10-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-10-07 · Grant · Acquired 1,362 · Balance 61,396 F1: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F3: Includes dividend equivalents reinvested in additional Phantom Stock Units.
Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	63,709	Reported balance After 2026-10-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-10-07 · Grant · Acquired 480 · Balance 63,709 F1: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Director's Deferred Compensation Plan. F5: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director.

F2: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash.

F3: Includes dividend equivalents reinvested in additional Phantom Stock Units.

F4: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Director's Deferred Compensation Plan.

F5: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

MONSANTO CO /NEW/

Report date June 07, 2018 · Filed June 07, 2018

Section 16 reporting ended · disclosed 2018-06-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-06-07 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2018-06-07 · Disposition to issuer · Disposed 65,405 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-06-07 transaction · row 4 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 4 · 2018-06-07 · Disposition to issuer · Disposed 36,899 · Balance 0 F4: Represents restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-06-07 transaction · row 5 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 5 · 2018-06-07 · Disposition to issuer · Disposed 69,772 · Balance 0 F5: Represents performance-based restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Common StockSEC Table I · non-derivative	IndirectBy trust	Reported balance After 2018-06-07 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2018-06-07 · Disposition to issuer · Disposed 27,769 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan	Reported balance After 2018-06-07 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2018-06-07 · Disposition to issuer · Disposed 7,109 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.45	Direct	Reported balance After 2018-06-07 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-06-07 · Disposition to issuer · Disposed 31,450 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.48	Direct	Reported balance After 2018-06-07 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2018-06-07 · Disposition to issuer · Disposed 41,450 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.05	Direct	Reported balance After 2018-06-07 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-06-07 · Disposition to issuer · Disposed 42,440 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $112.82	Direct	Reported balance After 2018-06-07 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-06-07 · Disposition to issuer · Disposed 39,890 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.34	Direct	Reported balance After 2018-06-07 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2018-06-07 · Disposition to issuer · Disposed 82,120 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
Deferred Payment Plan Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-06-07 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2018-06-07 · Disposition to issuer · Disposed 9,972 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Phantom Share UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-06-07 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2018-06-07 · Disposition to issuer · Disposed 12,683 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F4: Represents restricted stock units.

F5: Represents performance-based restricted stock units.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 07, 2026 Filed Oct 9, 2026 20:02 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	480	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001243982-26-000002 · wk-form4_1791576162.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,709 Underlying: Common Stock · 480 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Director's Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Director's Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Director's Deferred Compensation Plan. F5 · balance_after: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026. Read SEC document
October 07, 2026 Filed Oct 9, 2026 20:02 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,362	$63.25 Strike: $0.00	$86,146.50	Disclosure SEC source: 0001243982-26-000002 · wk-form4_1791576162.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,396 Underlying: Common Stock · 1,362 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · shares: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F2 · price: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F3 · balance_after: Includes dividend equivalents reinvested in additional Phantom Stock Units. Read SEC document
May 07, 2026 Filed May 11, 2026 20:26 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,628	$73.69 Strike: $0.00	$119,967.32	Disclosure SEC source: 0000915389-26-000118 · wk-form4_1778531195.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,034 Underlying: Common Stock · 1,628 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash. Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:08 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	408	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000915389-26-000084 · wk-form4_1775851727.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,408 Underlying: Common Stock · 408 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes dividend equivalents reinvested in additional Phantom Stock Units. Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:08 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,159	$74.27 Strike: $0.00	$86,078.93	Disclosure SEC source: 0000915389-26-000084 · wk-form4_1775851727.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,970 Underlying: Common Stock · 1,159 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · shares: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F2 · price: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral of a portion of director's retainer fees that would otherwise have been paid in cash. F3 · balance_after: Includes dividend equivalents reinvested in additional Phantom Stock Units. Read SEC document
October 07, 2025 Filed Oct 9, 2025 22:22 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	487	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001243982-25-000009 · wk-form4_1760048574.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,811 Underlying: Common Stock · 487 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F3 · balance_after: Includes 1,178 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 07, 2025 Filed Oct 9, 2025 22:22 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,340	$62.35 Strike: $0.00	$83,549.00	Disclosure SEC source: 0001243982-25-000009 · wk-form4_1760048574.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,324 Underlying: Common Stock · 1,340 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees into the director's stock account of the Director's Deferred Compensation Plan, which would otherwise have been paid in cash. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees into the director's stock account of the Director's Deferred Compensation Plan, which would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees into the director's stock account of the Director's Deferred Compensation Plan, which would otherwise have been paid in cash. F3 · balance_after: Includes 1,178 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents. Read SEC document
August 27, 2025 Filed Aug 28, 2025 20:08 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	PurchaseCommon Stock	1,500	$68.29	$102,427.50	Disclosure SEC source: 0001243982-25-000007 · wk-form4_1756411705.xml · nonDerivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,520 Read SEC document
May 01, 2025 Filed May 5, 2025 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,575	$76.22 Strike: $0.00	$120,046.50	Disclosure SEC source: 0000915389-25-000117 · wk-form4_1746475502.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,806 Underlying: Common Stock · 1,575 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 1, 2026, and are payable only in cash. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 1, 2026, and are payable only in cash. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 1, 2026, and are payable only in cash. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 1, 2026, and are payable only in cash. F3 · balance_after: Includes 16 units credited since April 7, 2025, as hypothetical reinvestment of dividend equivalents. Read SEC document
April 07, 2025 Filed Apr 9, 2025 20:19 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	412	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000915389-25-000090 · wk-form4_1744229946.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,215 Underlying: Common Stock · 412 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 1,421 units credited since October 7, 2024, as hypothetical reinvestment of dividend equivalents. Read SEC document
April 07, 2025 Filed Apr 9, 2025 20:19 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,134	$73.65 Strike: $0.00	$83,519.10	Disclosure SEC source: 0000915389-25-000090 · wk-form4_1744229946.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,803 Underlying: Common Stock · 1,134 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · shares: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral of a portion of director's retainer fees into the director's stock account of the Director's' Deferred Compensation Plan. F2 · price: Voluntary deferral of a portion of director's retainer fees into the director's stock account of the Director's' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral of a portion of director's retainer fees into the director's stock account of the Director's' Deferred Compensation Plan. F3 · balance_after: Includes 1,421 units credited since October 7, 2024, as hypothetical reinvestment of dividend equivalents. Read SEC document
October 07, 2024 Filed Oct 9, 2024 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	277	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000915389-24-000216 · wk-form4_1728504317.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,248 Underlying: Common Stock · 277 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F3 · balance_after: Includes 633 units credited since May 2, 2024 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 07, 2024 Filed Oct 9, 2024 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	788	$109.27 Strike: $0.00	$86,104.76	Disclosure SEC source: 0000915389-24-000216 · wk-form4_1728504317.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,971 Underlying: Common Stock · 788 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees into the director's stock account of the Director's Deferred Compensation Plan, which would otherwise have been paid in cash. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees into the director's stock account of the Director's Deferred Compensation Plan, which would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees into the director's stock account of the Director's Deferred Compensation Plan, which would otherwise have been paid in cash. F3 · balance_after: Includes 633 units credited since May 2, 2024 as hypothetical reinvestment of dividend equivalents. Read SEC document
May 02, 2024 Filed May 6, 2024 20:03 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,252	$95.92 Strike: $0.00	$120,091.84	Disclosure SEC source: 0000915389-24-000153 · wk-form4_1715025783.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,550 Underlying: Common Stock · 1,252 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 2, 2025, and are payable only in cash. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 2, 2025, and are payable only in cash. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 2, 2025, and are payable only in cash. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 2, 2025, and are payable only in cash. F3 · balance_after: Includes 41 units credited since April 05, 2024, as hypothetical reinvestment of dividend equivalents. Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	303	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000915389-24-000123 · wk-form4_1712693135.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,257 Underlying: Common Stock · 303 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 808 units credited since October 6, 2023, as hypothetical reinvestment of dividend equivalents. Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	811	$99.83 Strike: $0.00	$80,962.13	Disclosure SEC source: 0000915389-24-000123 · wk-form4_1712693135.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,954 Underlying: Common Stock · 811 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral of a portion of director's retainer fees into the director's stock account of the Director's' Deferred Compensation Plan. F2 · price: Voluntary deferral of a portion of director's retainer fees into the director's stock account of the Director's' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral of a portion of director's retainer fees into the director's stock account of the Director's' Deferred Compensation Plan. F3 · balance_after: Includes 808 units credited since October 6, 2023, as hypothetical reinvestment of dividend equivalents. Read SEC document
October 06, 2023 Filed Oct 11, 2023 20:02 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	408	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000915389-23-000154 · wk-form4_1697054517.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,335 Underlying: Common Stock · 408 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 774 units credited since May 4, 2023 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 06, 2023 Filed Oct 11, 2023 20:02 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,182	$73.92 Strike: $0.00	$87,373.44	Disclosure SEC source: 0000915389-23-000154 · wk-form4_1697054517.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,927 Underlying: Common Stock · 1,182 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Director's Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Director's Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Director's Deferred Compensation Plan. F3 · balance_after: Includes 774 units credited since May 4, 2023 as hypothetical reinvestment of dividend equivalents. Read SEC document
May 04, 2023 Filed May 8, 2023 20:18 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,396	$78.84 Strike: $0.00	$110,060.64	Disclosure SEC source: 0000915389-23-000113 · wf-form4_168357706431792.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,971 Underlying: Common Stock · 1,396 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 4, 2024, and are payable only in cash. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 4, 2024, and are payable only in cash. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 4, 2024, and are payable only in cash. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 4, 2024, and are payable only in cash. F3 · balance_after: Includes 32 units credited since April 10, 2023 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:04 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	369	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000915389-23-000069 · wf-form4_168132985313135.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,543 Underlying: Common Stock · 369 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 559 units credited since October 7, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:04 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	802	$81.93 Strike: $0.00	$65,707.86	Disclosure SEC source: 0000915389-23-000069 · wf-form4_168132985313135.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,174 Underlying: Common Stock · 802 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 559 units credited since October 7, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 07, 2022 Filed Oct 12, 2022 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	417	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-22-033477 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,813 Underlying: Common Stock · 417 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 1,027 units credited since May 5, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 07, 2022 Filed Oct 12, 2022 20:05 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	976	$72.39 Strike: $0.00	$70,652.64	Disclosure SEC source: 0000899243-22-033477 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,396 Underlying: Common Stock · 976 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 1,027 units credited since May 5, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document
May 05, 2022 Filed May 9, 2022 20:35 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,041	$105.67 Strike: $0.00	$110,002.47	Disclosure SEC source: 0000899243-22-017254 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,393 Underlying: Common Stock · 1,041 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F3 · balance_after: Includes 46 units credited since April 1, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:06 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	270	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-22-013715 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,306 Underlying: Common Stock · 270 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 353 units credited since October 1, 2021 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:06 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	587	$111.38 Strike: $0.00	$65,380.06	Disclosure SEC source: 0000899243-22-013715 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,036 Underlying: Common Stock · 587 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 353 units credited since October 1, 2021 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 01, 2021 Filed Oct 5, 2021 15:16 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	294	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-21-039039 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,096 Underlying: Common Stock · 294 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 551 units credited since May 6, 2021 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 01, 2021 Filed Oct 5, 2021 15:16 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	661	$102.50 Strike: $0.00	$67,752.50	Disclosure SEC source: 0000899243-21-039039 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,802 Underlying: Common Stock · 661 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 551 units credited since May 6, 2021 as hypothetical reinvestment of dividend equivalents. Read SEC document
May 06, 2021 Filed May 10, 2021 17:20 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	807	$124.04 Strike: $0.00	$100,100.28	Disclosure SEC source: 0000899243-21-018850 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,590 Underlying: Common Stock · 807 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. Read SEC document
April 05, 2021 Filed Apr 7, 2021 18:48 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	270	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-21-015238 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,846 Underlying: Common Stock · 270 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 349 units credited since October 2, 2020 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 05, 2021 Filed Apr 7, 2021 18:48 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	587	$111.16 Strike: $0.00	$65,250.92	Disclosure SEC source: 0000899243-21-015238 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,576 Underlying: Common Stock · 587 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 349 units credited since October 2, 2020 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 02, 2020 Filed Oct 6, 2020 15:23 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	384	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-20-027550 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,640 Underlying: Common Stock · 384 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 187 units credited since May 7, 2020 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 02, 2020 Filed Oct 6, 2020 15:23 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	834	$78.17 Strike: $0.00	$65,193.78	Disclosure SEC source: 0000899243-20-027550 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,256 Underlying: Common Stock · 834 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 187 units credited since May 7, 2020 as hypothetical reinvestment of dividend equivalents. Read SEC document
May 07, 2020 Filed May 11, 2020 17:46 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,654	$60.47 Strike: $0.00	$100,017.38	Disclosure SEC source: 0000899243-20-012548 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,235 Underlying: Common Stock · 1,654 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. Read SEC document
April 03, 2020 Filed Apr 6, 2020 23:04 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	668	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-20-010335 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,743 Underlying: Common Stock · 668 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 960 units credited since October 4, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 03, 2020 Filed Apr 6, 2020 23:04 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,449	$45.09 Strike: $0.00	$65,335.41	Disclosure SEC source: 0000899243-20-010335 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,075 Underlying: Common Stock · 1,449 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 960 units credited since October 4, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 04, 2019 Filed Oct 8, 2019 13:06 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	424	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-19-025247 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,666 Underlying: Common Stock · 424 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 409 units credited since May 2, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 04, 2019 Filed Oct 8, 2019 13:06 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	920	$71.07 Strike: $0.00	$65,384.40	Disclosure SEC source: 0000899243-19-025247 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,242 Underlying: Common Stock · 920 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 409 units credited since May 2, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document
May 02, 2019 Filed May 6, 2019 13:57 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	1,289	$77.63 Strike: $0.00	$100,065.07	Disclosure SEC source: 0000899243-19-012154 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,913 Underlying: Common Stock · 1,289 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F3 · balance_after: Includes 20 units credited since April 5, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 05, 2019 Filed Apr 9, 2019 13:24 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	366	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-19-010313 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,604 Underlying: Common Stock · 366 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 352 units credited since October 5, 2018 as hypothetical reinvestment of dividend equivalents. Read SEC document
April 05, 2019 Filed Apr 9, 2019 13:24 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	796	$82.38 Strike: $0.00	$65,574.48	Disclosure SEC source: 0000899243-19-010313 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,238 Underlying: Common Stock · 796 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 352 units credited since October 5, 2018 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 05, 2018 Filed Oct 9, 2018 15:32 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	332	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-18-026375 · doc4.xml · derivative · entry 2 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,090 Underlying: Common Stock · 332 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F4 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F4 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 248 units credited since April 6, 2018 as hypothetical reinvestment of dividend equivalents. Read SEC document
October 05, 2018 Filed Oct 9, 2018 15:32 UTC	EASTMAN CHEMICAL CO EMN · Entity 1780	GrantPhantom Stock Units · Derivative	664	$91.05 Strike: $0.00	$60,457.20	Disclosure SEC source: 0000899243-18-026375 · doc4.xml · derivative · entry 1 BEGEMANN BRETT D · CIK 0001243982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,758 Underlying: Common Stock · 664 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Voluntary deferral at election of director of a portion of director's retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 248 units credited since April 6, 2018 as hypothetical reinvestment of dividend equivalents. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerPhantom Share Units · Derivative	12,683	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 12 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,683 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerDeferred Payment Plan Restricted Stock Unit · Derivative	9,972	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 11 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,972 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerStock Option (Right to Buy) · Derivative	82,120	Not disclosed Strike: $91.34	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 10 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,120 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerStock Option (Right to Buy) · Derivative	39,890	Not disclosed Strike: $112.82	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 9 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,890 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerStock Option (Right to Buy) · Derivative	42,440	Not disclosed Strike: $106.05	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 8 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,440 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerStock Option (Right to Buy) · Derivative	41,450	Not disclosed Strike: $90.48	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 7 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,450 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:54 UTC	MONSANTO CO /NEW/ MON · Entity 165931	Disposition to issuerStock Option (Right to Buy) · Derivative	31,450	Not disclosed Strike: $89.45	Not disclosed	Disclosure SEC source: 0000899243-18-015475 · doc4.xml · derivative · entry 6 BEGEMANN BRETT D · CIK 0001243982 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,450 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.